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Abstract
Background: While essential medicines have been made more available in all but the most remote areas in low
and middle income countries (L/MICs) over the past years, inappropriate and incorrect use of good quality
medicines remains a key impediment for public health. In addition, as medicines have a potential to cause harm
(medicine risks), adequate awareness by medicine users of the risks of adverse reactions is essential, especially as
self-medication is common in L/MICs. This study aimed to investigate the awareness of Lao residents regarding
medicine risks in Vientiane Capital, Lao People’s Democratic Republic.
Methods: Face-to-face interviews using structured questionnaires of 144 residents older than 16 years were carried
out in 12 randomly selected villages out of the 146 villages of Vientiane Capital with at least one health facility.
Results: The respondents were mainly (85.0 %) the heads of households or their husband/spouse . The majority
of the respondents were unaware (61.8 %) of medicine risks. Compared to residents living in the urban district of
Xaysetha, living in peri-urban and even more in rural areas were identified as factors associated with being unaware
of medicine risks [adjusted odds ratio (aOR) =3.3, 95 % Confidence Interval (CI) = 1.1–9.4]) and aOR =7.5 (95 % CI =
2.3–24.2), respectively]. In addition, more than half of the respondents had never heard of poor quality medicines,
with a higher rate in rural/peri-urban compared to urban districts (55.6 % vs 38.9 %, respectively, p = 0.02). Finally,
approximately one third of all respondents thought that traditional medicines could not cause harm.
Conclusions: Overall, these results suggest a lack of awareness about medicinal product risks. Differences according
to the place of residence are apparent and could be partly explained by a lower level of training of healthcare
providers in contact with the population in the rural districts in particular. Communication on medicinal product
risks to patients through well-trained healthcare providers could probably make a valuable contribution towards the
appropriate use of medicines in L/MICs.
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Background
Over the past 20 years, the rapid expansion of health
markets, especially in low and middle income countries
(L/MICs) in Asia and in Africa, has made many medi-
cines available in all but the most remote areas [1]. This
growing market, although providing pharmacological
treatments to many patients, has raised problems of drug
safety associated with inappropriate and incorrect use of
medicines. The World Health Organization (WHO) esti-
mates that more than 50 % of all medicines are prescribed,
dispensed or sold inappropriately and that half of all
patients fail to take medicines correctly [2].
In L/MICs countries, medicine users themselves are
key actors for an appropriate and correct use of medi-
cines. Indeed, self-medication is a common practice,
partly because most medicines are available without any
prescription [3]. Moreover, people commonly use trad-
itional medicines for which safety is relatively unknown
[4, 5]. Finally, people in L/MICs countries are more and
more exposed to the growing market of poor quality
medicines [6]. Consequently, the threat of adverse drug
reactions (ADRs) is a major issue in these countries.
In a survey performed in Zimbabwe, 65 % of the inter-
viewees (adults members of households) were unaware
of over-the-counter (OTC) medicine risks [7]. Develop-
ing people’s awareness of the potential harmful effects of
medicinal products may be particularly relevant to
improve their appropriate and correct use.
Lao People’s Democratic Republic (Lao PDR) is a lower-
middle income country in South-East Asia. Although ef-
forts have been made to improve the use of medicines
since the adoption of the National Drug Policy in 1993
[8], some important issues remain, such as the low quality
of private pharmacy services [9], common self-medication
[10, 11], inappropriate prescribing and dispensing of med-
icines in public health facilities [12], and the existence of
poor quality medicines in the market [13].
The aim of this study was to investigate the awareness
of the population on medicine risks in Vientiane Capital,
Lao PDR. In addition, we aimed to study the awareness
of the population on traditional medicine risks and on
the existence of poor quality medicines.
Methods
Study population
This cross-sectional study was conducted between August
and November 2012 in Vientiane Capital. Vientiane
Capital is composed of nine districts and 483 villages and
had an estimated population of 797,130 inhabitants in
2012 [14].
With the aim to get a representative study population
of Vientiane Capital districts, two urban districts (Xaysetha
and Sikhottabong) were randomly selected among the four
urban ones, one (Naxaithong) among the three peri-urban
districts and one (Sangthong) among the two rural districts
(simple random samplings). Differentiation of the districts
into urban, peri-urban and rural was based on previous
publications [15, 16].
In a previous study in Zimbabwe, the prevalence of
citizens unaware of the potential harm induced by OTC
drugs was 65 % [7]. Based on this prevalence, we aimed
to include 87 to 350 villagers, allowing a precision be-
tween 5 and 10 %. This interval was conditioned by the
lack of availability of skilled interviewers with medical or
pharmaceutical degree. We calculated that three inter-
viewers could interview 10 villagers per village and per
day. With an estimated rate of refusal of 20 %, 12
villagers were thus included per village. Three villages
per district (this number was chosen for convenience)
were randomly selected by simple sampling among the
villages with at least one health facility (health centre,
hospital, private clinic or private pharmacy), represent-
ing 8.2 % (n = 12) of all the eligible villages (n = 146) in
the four surveyed districts.
In the villages where a list of the households was avail-
able (n = 8), 12 households were selected by systematic
random sampling. Systematic sampling involves a ran-
dom start and then proceeds with the selection of every
kth element from then onwards [17]. For each village, k
was calculated as the total number of households di-
vided by 12. In the other villages (n = 4) a list of ‘clusters
of households’ was provided by the head of the village.
From this list, 12 clusters were selected by systematic
sampling and in each cluster one household was then
chosen at the time of the survey by the research team.
The head of the household or his/her wife/husband was
interviewed if available at the time of the visit. When s/
he was not available, another member of the household
was interviewed (≥16 years old).
Questionnaire and data collection
The questionnaire was developed for the purpose of the
study. It was structured into four sections related to:
sociodemography, medicinal products use, awareness of
medicinal product risks (including traditional medicines,
modern medicines and poor quality medicines) and
experience of ADR (Table 1).
Most of the questions were closed-ended questions (yes/
no or yes/no/do not know) and a few were open-ended.
The open-ended questions were read without mentioning
any predetermined answers, and the information collected
was coded based on identified thematic areas.
Two questions were used to define the awareness of
modern medicine risks. The first one was ‘Have you ever
heard what an ADR is?’. In addition, in order not to
underestimate the awareness of the population, a second
question was added ‘Do you think that modern medicines
can be harmful in case of normal use and normal
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Table 1 Questionnaire for survey of population awareness of risks related to medicinal products use
Answers
A. Sociodemographic characteristics
1. Gender o Male o Female
2. Age ____
3. Status in the household o Head of
household
o Spouse or husband of
head of household
o Other, specify ________
4. Occupation o Housekeeper o Farmer o Other job
o Retired/disabled o Student







7. Level of education o Secondary school
or higher
o Primary school or no
education
8. Can you read? o Yes o No
9. Do you have easy access to internet? o Yes o No
B. Medicinal product use
1. Have you ever consumed modern medicine(s)? o Yes o No
Was the last time during the last 12 months? o Yes o No
If yes, name(s) of the medicine(s) and its (their) indication(s) ________ ________
2. Have you ever consumed traditional medicine(s)? o Yes o No
Was the last time during the last 12 months? o Yes o No
If yes, name(s) of the medicine(s) and its (their) indication(s) ________ ________
C. Awareness of medicinal product risks
1. Do you think that modern medicines can be harmful in case of normal
use and normal doses?
o Yes o No o Do not know
Comment(s)_____________________________________________
2. Do you think that modern medicines can be harmful in case of overdosage? o Yes o No o Do not know
3. Do you think that traditional medicines can be harmful in case of normal use
and normal doses?
o Yes o No o Do not know
4. Do you think that traditional medicines can be harmful in case of
overdosage?
o Yes o No o Do not know
5. Have you ever heard what an adverse drug reaction is? o Yes o No
Comment(s)_____________________________________________
6. Have you ever heard of poor quality medicines? o Yes o No
If yes, do you think that poor quality medicines can be harmful? o Yes o No o Do not know
Comment(s)_____________________________________________
7. Where have you heard of poor quality medicines? o Healthcare
providers
o Magazine, journal
o TV o Relative, friend o Other, specify
________
D. Experience of adverse drug reaction
1. Have you (or one of your relative) ever taken a medicine (modern
medicine, traditional medicine) that made you feel worse?
o Yes o No
If yes, please describe the reaction and the name(s) of the medicine(s)_________________________
A Pharmacovigilance system is a ‘drug monitoring’ system. This system works through spontaneous reporting of drug-related problems by health
care professionals and patients.
2. Would you agree to notify a drug-related problem to the national
pharmacovigilance center?
o Yes o No
Caillet et al. BMC Public Health  (2015) 15:590 Page 3 of 10
doses?’. This latter was adapted from another study [7].
In order to verify their understandings of these two
questions, the positive respondents were invited to give
comments.
A negative answer to the first question (ADR) and a
negative or a ‘do not know’ answer to the second one
were the criteria to consider a villager as unaware of
medicine risks.
The questionnaire was developed in English and trans-
lated into Lao by a Laotian pharmacist with strong back-
ground of English practice. The technical words were
checked by two Laotian pharmacists specialized in pub-
lic health. The questionnaire was then back-translated
into English by a Lao medical doctor with a Tropical
and International Health degree to make sure the first
translation was accurate. After translation and back-
translation, no discrepancies for the questions used for
the measures of the outcome were highlighted. We piloted
the questionnaire with four villagers (heads of household
or their spouse/husband) living in Vientiane to assess un-
derstanding and ease of completion. The respondents to
the pilot survey were asked to tell if all the words were
understood and they were also asked to explain in details
the choices of their answers, with a particular attention to
the questions of the Section C and D.
The questionnaires were administered by face-to-face
interviews by three trained physicians using local lan-
guage (i.e. Lao), either in the office of the head of the vil-
lage (in two villages), at the temple of the village (in one
village), or within the households (in nine villages).
Data analysis
Characteristics of those unaware versus aware of medi-
cine risks were compared using χ2 tests when all ex-
pected counts were above five, or otherwise with Fisher’s
exact tests. T-tests were used to compare quantitative
characteristics if the equality of the variances was con-
firmed by F-tests. If variances were not equal, Wilcoxon
tests were used.
To identify factors associated to the unawareness of
medicine risks, logistic regression was performed. The
following socio-economic characteristics were tested:
gender, age, educational level, district, monthly house-
hold income, status within the household, occupation,
ability to read and access to internet. The variables with
a p-value <0.20 after univariate analysis were entered
into a multivariate logistic regression model.
The goodness of fit of the final model was assessed
using the Hosmer and Lemeshow test. The results are
presented as odds-ratio (OR) or adjusted odds ratios
(aOR) and their 95 % confidence intervals (CI). Data ana-
lysis was carried out using SAS® 9.3 software (SAS Inst.,
Cary, North Carolina, USA). The level of significance was
set at 0.05 (two-sided).
Ethical approval
Written informed consent was obtained from all partici-
pants. Ethical clearance for the study was granted by the
Ethics Committee of the University of Health Sciences,
Ministry of Health of Laos.
Results
Respondent characteristics
A total of 144 Lao citizens were solicited and all
consented. An equal number of respondents in each
selected district (n = 36) were included. More women (n
= 108) than men (n = 36) were included and the mean
age was 45.1 (SD 12.5) years old. One-third of all respon-
dents (n = 47) were the heads of the household, with a ma-
jority of men (n = 32). Half (n = 74) were their spouses.
A total of 89 [61.8 % (95 % CI = 53.8–69.8)] respon-
dents were unaware of modern medicine risks (Table 2).
Respondents being unaware tended to have a lower level
of education than those being aware (55.1 vs 34.6 %,
p = 0.03). There were differences according to the dis-
trict (p < 0.001). Respondents being unaware tended to
live more in the rural district of Sangthong (33.7 vs
10.9 %, p < 0.01 respectively) and less in the urban dis-
trict of Xaysetha than those being aware (15.7 vs 40.0 %,
p < 0.01 respectively). The proportions of respondents
living in Sikhottabong (urban) or in Naxaithong (peri-
urban) were not statistically different between the re-
spondents being aware and unaware.
Medicinal product use
All the respondents claimed to have used a modern
medicine and 87 (60.4 %) a traditional medicine during
their lifetime. One-hundred and two (70.8 %) respon-
dents had used at least one medicine (modern or trad-
itional) within the last 12 months. Fifty-one (50.0 %) of
them could not give the names of the last modern medi-
cines used within the previous 12 months (Table 3). The
main indications of these unidentified modern medicines
were pain (n = 17), fever (n = 6), diabetes (n = 4), allergy
(n = 3), cough (n = 3), contraception (n = 2), hypertension
(n = 2) and hypercholesterolemia (n = 2). Among the
modern medicines that the respondents were able to
name, analgesics and vitamins were the most frequently
used. The analgesics were paracetamol or paracetamol in
combination with antihistamine and sympathomimetic
agents (n = 14), non-steroidal anti-inflammatory drugs (n
= 3), and metamizole (n = 1).
None of the 15 respondents could give a name for the
traditional medicines. However, most could give a descrip-
tion of the part of the plant used [(e.g. ‘leaves of a tree’
(n = 3) or ‘roots of a tree’ (n = 6)] and its indication [mainly
pain (n = 5), diabetes (n = 2) and gastritis (n = 2)].
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Factors potentially associated with being unaware vs
being aware of medicine risks
Occupation was not included in the multivariate regres-
sion model because of a strong collinearity with the
district. Indeed, there were significantly more farmers in
the rural and peri-urban districts as compared to urban
ones (38.6 % and 36.1 % vs 4.2 %, respectively, p < 0.01).
In the multivariate logistic regression model, the
district was the only significant variable potentially asso-
ciated with an increased risk of being unaware of risks
related to medicine use. Compared to the respondents of
the urban district of Xaysetha, the respondents in the
peri-urban (Naxaithong) and even more in the rural dis-
trict (Sangthong) were more likely to be unaware of medi-
cine risks [ aOR =3.3, (95 % CI =1.1–9.4) and aOR =7.5
(95 % CI = 2.3–24.2), respectively] (Table 4). The respon-
dents in the rural district were also more likely to be
unaware of medicine risks compared to those living in the
urban district of Sikhottabong [aOR = 4.5 (95 % CI =
1.3–15.1)] but no statistical differences were observed
between the respondents in Sikhottabong and those in
the peri-urban district of Naxaithong [aOR = 1.9 (95 %
CI = 0.7–5.7)].
Awareness of medicinal product safety
Among the 55 respondents who were qualified as aware
of modern medicine risks, 53 (96.4 %) had heard what
an ADR is. These respondents gave examples of symp-
toms of adverse reactions. The most commonly quoted
were allergic and gastro-intestinal symptoms. Sometimes
the respondents associated the culprit medicine to the
symptom (e.g.: ‘ampicillin can cause allergy’). Some re-
spondents also tried to define what an ADR is (ex: ‘it is
when new symptoms appear when you take a medicine’).
Of these 53 respondents, a majority (n = 45, 84.9 %) said
that modern medicines are potentially harmful in over-
dosage, but only five (9.4 %) believed that they can be
harmful at recommended doses.
Regarding traditional medicines, 83 (57.7 %) partici-
pants believed that they are not potentially harmful with
normal doses and with normal use, and about half of
Table 2 Socio-demographic characteristics of the respondents








Total 55 (38.2) 89 (61.8)
Age (years) 0.07
Mean ± SD 42.7 ± 10.6 46.5 ± 13.4
Gender 0.24
Male 17 (30.9) 19 (21.4)
Female 38 (69.1) 70 (78.6)
Status in the household 0.76
Head of household 16 (29.1) 31 (34.8)
Husband/spouse of the
head of household
29 (52.7) 45 (50.6)




35 (63.6) 42 (47.2)
Housekeeper 13 (23.6) 24 (27.0)
Farmer 7 (12.7) 23 (25.8)
Religion 0.52
Buddhism 55 (100.0) 87 (97.8)




>1,000,000 7 (13.0) 21 (24.1)
≤1,000,000 47 (87.0) 66 (75.9)
Level of education 0.03
Secondary or higher 36 (65.5) 40 (44.9)
No education or primary
school
19 (34.6) 49 (55.1)
Can read 0.74
Yes 52 (94.6) 82 (92.1)
No 3 (5.5) 7 (7.9)
Access to internet 0.08
Yes 8 (14.6) 5 (5.6)
No 47 (85.5) 84 (94.4)
District 0.001
Xaysetha 22 (40.0) 14 (15.7)
Sikhottabong 15 (27.3) 21 (23.6)
Naxaithong 12 (21.8) 24 (27.0)
Sangthong 6 (10.9) 30 (33.7)
*χ2, Fisher’s tests (qualitative characteristics) or t-test
(quantitative characteristics)






Traditional medicines 13 (12.7)
Anti-infectious 10 (9.8)
Medicines of gastro-intestinal disorders 8 (7.8)
Cardiovascular medicines 5 (4.9)
Antidiabetics 5 (4.9)
Other 2 (2.0)
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them (n = 39), representing 27.1 % of all the participants,
thought that they are safe in overdosage. In addition, 46
(31.9 %) and 54 (37.5 %) respondents had no opinion on
the potential noxiousness of traditional medicines in
case of normal use and in overdosage, respectively.
Awareness of the existence of poor quality medicines
One half (n = 68, 47.2 %) of the respondents had heard
of poor quality medicines, mainly through media (TV,
radio, papers; n = 41, 60.3 %) or through relatives/friends
(n = 16, 23.5 %). Those living in peri-urban/rural districts
Table 4 Factors influencing the awareness of the population regarding medicines risks: ‘unaware’ vs ‘aware’. Results of univariate
and multivariate analysis
Univariate analysis Multivariate analysis
Variables OR (95 % CI) p-value Adjusted OR (95 % CI) p-value
Age group (years) 0.10 0.11
≤40 1 1
[40–50] 0.9 (0.4–2.0) 0.8 (0.3–2.0)




Status in the household 0.72
Head of household 1
Husband/spouse of the head of household 0.8 (0.4–1.7)
Other 0.7 (0.2–1.9)
Occupation 0.10






Monthly household income (Lao Kip) 0.11 0.06
>1,000,000 1 1
≤1,000,000 2.1 (0.8–5.4) 2.8 (1.0–8.1)
Level of education 0.02 0.56
Secondary or higher 1 1
Primary school or no education 2.3 (1.2–4.7) 1.3 (0.6–2.9)
Ability to read 0.58
Yes 1
No 1.5 (0.4–6.0)
Access to internet 0.08 0.22
Yes 1 1
No 2.9 (0.9–9.2) 2.3 (0.6–8.5)
District <0.01 <0.01
Xaysetha 1 1
Sikhottabong 2.2 (0.9–5.6) 1.7 (0.6–4.8)
Naxaithong 3.1 (1.2–8.2) 3.3 (1.1–9.4)
Sangthong 7.9 (2.6–23.7) 7.5 (2.3–24.2)
OR, odds-ratio; CI, confidence interval
The occupation factor was not included in the multivariate model because of its strong collinearity with the district localization
Caillet et al. BMC Public Health  (2015) 15:590 Page 6 of 10
were significantly less aware of their existence in com-
parison to those in urban districts (38.9 % vs 55.6 %, re-
spectively, p = 0.02). In response to the question ‘Do you
think that poor quality medicines can be harmful?’, most
of the respondents (n = 59, 86.8 %) answered yes and 8
(11.8 %) had no opinion. Respondents were invited to
comment on this latter question. Among the respon-
dents who gave a comment (n = 40), 18 (45 %) expressed
concerns regarding the risk of inefficacy of the poor
quality medicines, 11 (27.5 %) about the potential occur-
rence of ADRs (e.g. ‘harmful for the liver’, ‘harmful for
the kidney’) and 6 (15 %) expressed both concerns of
inefficacy and potential occurrence of ADRs.
Experience of adverse reaction to modern or traditional
medicines
Fifty-two (36.1 %) respondents claimed to have encoun-
tered a medicine that ‘made them or their relative feel
worse’, most of them being aware of medicine risks (60 %
versus 21 % being unaware, p < 0.001). All described the
reaction observed, but only half (n = 28) could give the
name or the pharmacological class of the medicine in-
volved, an antibiotic being involved in 18 cases (64.3 %).
Symptoms of allergy such as ‘rash’, ‘shock’, ‘dyspnea’ or
‘oedema’ were described by 35 (67.3 %) respondents
among whom five were serious adverse reactions (e.g.
angioneurotic oedema). Forty percent of the cases of
allergy involved antibiotics (n = 14), one case involved
the ‘leaves of a tree’ and 15 (42.9 %) respondents did not
know the name of the medicine(s) involved. Gastro-
intestinal symptoms (9 cases, 17.3 %) and general symp-
toms such as ‘fatigue’ or ‘dizziness’ (15 cases, 28.9 %)
were also noted. A total of 140 (97.2 %) respondents
would agree to notify an ADR to the concerned author-
ity in the future.
Discussion
In this population-based study, the majority of the
respondents were unaware of modern medicine risks.
Most of the respondents qualified as aware had an inad-
equate awareness since most thought that modern medi-
cines can be harmful only in overdosage. As for modern
medicines, the awareness of traditional medicine risks
was limited. Half of the participants were not aware of
the existence of poor quality medicines in the market.
The median age (47 years old) of our population is
higher than that of the population at national level since
75 % of people were aged between 15 and 45 years old
in 2005 [18]. More women than men were interviewed
mainly because interviews were performed during work-
ing hours. Nevertheless, even if our population does not
strictly represent the general population of lao adults,
85 % of the respondents were the heads of household or
their husband/spouse, who play an important role in
healthcare choices for the whole family in L/MICs [19–21].
No citizen refused to participate in the study. Government
staffs have a strong influence on citizens in the Lao PDR.
The 100 % response rate can thus result from the first
contact of the citizens that was made by the head of the
village or his mandated assistant. Whereas these latter
were present during some interviews, they agreed to stay
apart. However, when the interviews were performed in
the households it was difficult to maintain strict confiden-
tiality, as other family members or neighbours sometimes
came to listen.
In our survey, only one-fourth of the population is
rural. As 71 % of the population of the Lao PDR lived in
rural areas in 2007/2008 [22], we can reasonably assume
that the awareness of the general population of Lao PDR
regarding the issue of medicinal product risks is lower
than that observed in our study. This is highlighted by
the significant differences of awareness observed be-
tween the districts, respondents in the rural district
having a higher risk of being unaware than those in
urban districts. Further data [18, 23] have shown that
the distribution of health facilities was different accord-
ing to the districts. Private clinics – run by medical
doctors with university degree –, and class I commu-
nity pharmacies – run by pharmacists with university
degree –, are more prevalent in the urban districts of
Xaysetha (84.1 and 40.0/100,000 inhabitants, respect-
ively) and Sikhottabong (44.0 and 13.0/ 100,000 inhabi-
tants respectively) than in the peri-urban district of
Naxaithong (30.8 and 1.7 /100,000 inhabitants, respect-
ively) and in the rural district of Sangthong (24.8 and
4.1/100,000 inhabitants, respectively). Therefore, we
suggest that whereas people in rural areas have access
to health facilities, urban residents have a better oppor-
tunity to receive information from healthcare providers
of higher level of training. Whereas respondents in the
urban district of Sikhottabong have a significant higher
awareness than those in the rural district of Sangthong,
there were no differences with those in the peri-urban
district of Naxaithong. This could be explained by the
distribution of health facilities in Sikhottabong that is
in between that of the peri-urban district of Naxaithong
and of the urban district of Xaysetha. In addition, as
suggested by Syhakhang et al. [16], people in urban
areas may have better opportunity to receive informa-
tion on medicines from the regulatory authority. More
investigations are needed to assess other potential fac-
tors that might explain the differences between the
districts.
In the absence of validated questionnaire to assess the
awareness of the population on medicine risks when
they are used with normal doses, our questionnaire was
developed for the purpose of this study. While its reliabil-
ity and validity have not been tested, the questionnaire
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was submitted to four experts in public health, epidemi-
ology and pharmacology for an opinion, before being
translated into Lao. The term ADR is defined by the
WHO as “a response to a drug which is noxious and unin-
tended and which occurs at doses normally used in
humans”[24]. It is used for communication on drug safety
in validated sources of information on medicines (i.e. sum-
mary of products characteristics and leaflets). However,
when this term has never been heard by a villager, it does
not necessarily mean that he is not aware of medicine
risks. We thus combined this question to a second one
(‘Do you think that modern medicines can be harmful in
case of normal use and normal doses?’) to define our out-
come of interest.
We observed that even when they were qualified as
aware of medicine risks, the large majority of our re-
spondents think that modern medicines are potentially
harmful only in overdosage. In addition, the majority of
the respondents in our study considers traditional medi-
cines as safe or has no opinion, even in overdosage.
Therefore, strategies to raise awareness of the population
on drug safety, without scaring patients from using me-
dicinal products are needed, with special attention to
rural areas. This is particularly important in a country
where most medicines, even the most harmful, are read-
ily available OTC. Mass media campaigns have previ-
ously shown promising results in health promotion in L/
MICs [25, 26]. Adequate key messages on drug safety,
for example targeting medicinal products commonly in-
volved in ADRs could be relevant. For this purpose, drug
safety data in the Lao PDR are needed.
Half of our respondents had never heard of poor qual-
ity medicines. Although efforts made by the government
since the implementation of the National Drug Policy
[8] have allowed reduction in the proportion of poor
quality medicines in the market [27], the threat is still
real [13]. Most of the people being aware of poor quality
medicines had been informed through media in our study.
Initiatives to raise awareness of the population such as the
‘Mekong Cartoon Contest’ in 2011 (“Beware of counter-
feiting, danger is calling!”) with online diffusion of the
cartoons [28], need to be continued.
Half of our participants could not name the last medi-
cines used within the last year. This can be due to recall
bias, illiteracy concerns or non-adherence to prescribed
medications (with regard to chronic diseases medica-
tions). This could also result from a lack of identification
of medicines, as previously observed in two studies in
which half of the medicines sold in private or public
pharmacies had no label [9, 29]. As accepted important
sources of information on drug use and safety [30], the
provision of labels and package inserts should be en-
dorsed. It should be mentioned that a new article (2012)
of the Laotian law on drug and medical products states
that medicine users should receive clear and complete
information from medicines suppliers. However, package
inserts are often written in medical jargon and too many
information is generally provided. They are thus difficult
to understand [31]. When printed in foreign languages,
they can be incomprehensible for patients, especially in
rural areas [7]. Distributed by pharmacists and other
health professionals, well-adapted model sets of mini-
mum information developed in a way that is relevant to
each population – e.g. using regional languages and il-
lustrations [32] – have previously shown good effective-
ness [33, 34]. The best effects on patients knowledge are
evident when both written and oral information on med-
icines are provided [35]. In a previous study by Stenson
et al. [9], oral information were not transmitted for more
than half of medicines sold in laotian pharmacies of low
level (class III). Engaging all healthcare professionals in
providing adequate oral information is essential – espe-
cially in the context of high illiteracy – , not only to
improve patients’ understanding of their medication,
but also to build trustworthy health system [36–38].
Enhancing the training of pharmacist and medical stu-
dents on drug safety communication seems necessary in
the Lao PDR.
In line with the efforts to improve the use of medi-
cines, the Lao PDR has recently (2013) become an asso-
ciate member of the WHO Programme for International
Drug Monitoring [39]. Drug safety monitoring requires
the involvement of healthcare professionals. In addition,
central, provincial or district level drug information cen-
ters for patients who seek information on medicines
could help transforming medicine users from passive re-
cipients to active partners [40–42]. In remote areas,
community health workers or community leaders have
proved highly effectiveness in promoting health [43, 44]
and could constitute mediators between the population
and a drug information center. At last, mobile technolo-
gies and web-based systems have recently proved good
performance in health care processes in Asia [45, 46].
Conclusion
We have demonstrated concerns about the awareness of
the risks of medicinal products among the population of
Vientiane Capital. Differences according to the place of
residence are apparent and could be partly explained by
a lower level of training of healthcare providers in con-
tact with the population in the rural districts in particu-
lar. The most important recommendation would be to
invest more in education and information about these
risks for the population. This could make a valuable
contribution towards the improvement of the appropri-
ate and correct use of medicines, and thus towards drug
safety, in Lao PDR and in L/MICs in general.
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